Cited by 1,283Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPoisoning and overdose treatments

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Drug Overdose Deaths in the United States, 1999–2020

Open access

Hedegaard, Holly, Miniño, Arialdi, Spencer, Merianne Rose, Warner, Margaret·2021

Open this paper in CoChat — free account Open PDF

Abstract

This report uses the most recent data from the National Vital Statistics System (NVSS) to update statistics on deaths from drug overdose in the United States, showing rates by demographic group and by specific types of drugs involved (such as opioids or stimulants), with a focus on changes from 2019 to 2020.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.15620/cdc:112340

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

National Center for Health Statistics Guidelines for Analysis of Trends.
Ingram, D. D., Malec, D. J., Makuc, D. M., Kruszon‐Moran, D., Gindi, R. M., Albert, M., Beresovsky, V., Hamilton, B. E., Holmes, J. S., Schiller, J. S., et al. (2018) · PubMed · Cited by 783
Drug Overdose Deaths in the United States, 2003–2023
Garnett, M. F., Miniño, A., Joyce, M. A., Driscoll, A., & Valenzuela, C. (2024) · doi:10.15620/cdc/170565 · Cited by 390
Self-citation
Deaths: Final Data for 2019
Xu, J., Murphy, S., Arias, E., & Kochanek, K. D. (2021) · doi:10.15620/cdc:106058 · Cited by 107
The contribution of drug-related deaths to the US disadvantage in mortality
Barbiéri, M. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy288 · Cited by 30

Flagged first, then by citations

Show all 4 references

Research works printed but not linked: 1

Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Fed Regist 62(210):58782-90. 1997. Available from: https://www.govinfo.gov/content/ pkg/FR-1997-10-30/pdf/97-28653.pdf.

Sorted by citations

Items 301–400 of 1,002

Parenting a 6-Year Old Is Not What I Planned in Retirement: Trauma and Stress among Grandparents Due to the Opioid Crisis
Davis, M. T., Warfield, M. E., Boguslaw, J., Roundtree-Swain, D., & Kellogg, G. (2020) · Journal of Gerontological Social Work · doi:10.1080/01634372.2020.1752872 · Cited by 33
Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket
Lamy, F. R., Daniulaityte, R., Barratt, M. J., Lokala, U., Sheth, A., & Carlson, R. G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108115 · Cited by 33
A Case Series of Etizolam in Opioid-Related Deaths
Gevorkyan, J., Kinyua, J., Pearring, S., & Rodda, L. N. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa146 · Cited by 33
An analytical platform for near real-time drug landscape monitoring using paraphernalia residues
Appley, M. G., Robinson, E. L., Thomson, A., Russell, E., & Sisco, E. (2023) · Forensic Chemistry · doi:10.1016/j.forc.2023.100489 · Cited by 33
Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program
Hillman, R. T., Sánchez-Migallón, A., Meyer, L. A., Iniesta, M. D., Cain, K. E., Siverand, A. M., Veum, S. P. L., Suki, T. S., Lasala, J. D., & Ramirez, P. T. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.03.101 · Cited by 33
Efficacy of Short Message Service Text Messaging Interventions for Postoperative Pain Management: Systematic Review
Buck, C., Keweloh, C., Bouras, A., & Simoes, E. J. (2021) · JMIR mHealth and uHealth · doi:10.2196/20199 · Cited by 33
Opioid Prescription Patterns for Children Following Laparoscopic Appendectomy
Sonderman, K. A., Wolf, L. L., Madenci, A. L., Kwon, N. K., Armstrong, L. B., Wanis, K. N., Taylor, K. K., Uribe‐Leitz, T., Koehlmoos, T. P., Ricca, R. L., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000003171 · Cited by 32
Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010–2017
Rowe, C. L., Riley, E. D., Eagen, K., Zevin, B., & Coffin, P. O. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107571 · Cited by 32
Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids
Roxburgh, A., Hall, W., Gisev, N., & Degenhardt, L. J. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.035 · Cited by 33
The impact of naturalistic cannabis use on self-reported opioid withdrawal
Bergeria, C. L., Huhn, A. S., & Dunn, K. E. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108005 · Cited by 32
“Narcan Encounters:” Overdose and Naloxone Rescue Experiences among People who use Opioids
Kahn, L. S., Wozniak, M., Vest, B. M., & Moore, C. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1748165 · Cited by 32
Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography—tandem mass spectrometry
da Cunha, K. F., Rodrigues, L. C., Huestis, M. A., & Costa, J. L. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461241 · Cited by 32
The Need for Multiple Naloxone Administrations for Opioid Overdose Reversals: A Review of the Literature
Abdelal, R., Banerjee, A. R., Carlberg-Racich, S., Darwaza, N., Ito, D., & Epstein, J. (2022) · Substance Abuse · doi:10.1080/08897077.2021.2010252 · Cited by 33
Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets
Amiri, S., Hirchak, K. A., Lutz, R. B., McDonell, M. G., McPherson, S., Roll, J. M., & Amram, O. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.024 · Cited by 32
Opioid Use Disorder Treatment Facilities With Programs for Special Populations
Hadland, S. E., Jent, V. A., Alinsky, R. H., Marshall, B. D. L., Mauro, P. M., & Cerdá, M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.03.022 · Cited by 32
Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview
Hasin, D., Shmulewitz, D., Stohl, M., Greenstein, E., Roncone, S., Aharonovich, E., & Wall, M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108294 · Cited by 31
Public drug use in eight U.S. cities: Health risks and other factors associated with place of drug use
Sutter, A., Curtis, M., & Frost, T. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.11.007 · Cited by 31
The impact of expanded Medicaid eligibility on access to naloxone
Frank, R. G., & Fry, C. (2019) · Addiction · doi:10.1111/add.14634 · Cited by 31
Correlates of Transactional Sex Among a Rural Population of People Who Inject Drugs
Allen, S. T., White, R. H., O’Rourke, A., Ahmad, N. J., Hazelett, T., Kilkenny, M. E., & Sherman, S. G. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02612-7 · Cited by 31
Operationalizing and selecting outcome measures for the HEALing Communities Study
Slavova, S. S., Larochelle, M. R., Root, E. D., Feaster, D. J., Villani, J., Knott, C. E., Talbert, J., Mack, A., Crane, D. A., Bernson, D., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108328 · Cited by 31
The Fast Track intervention’s impact on behaviors of despair in adolescence and young adulthood
Godwin, J. W., Bierman, K. L., Coie, J. D., Crowley, D. M., Dodge, K. A., Greenberg, M. T., Lochman, J. E., McMahon, R. J., & Pinderhughes, E. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016234117 · Cited by 31
Drug Mortality and Lost Life Years Among U.S. Midlife Adults, 1999–2015
Ruhm, C. J. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.03.014 · Cited by 31
Suspected heroin-related overdoses incidents in Cincinnati, Ohio: A spatiotemporal analysis
Li, Z., Xie, E., Crawford, F. W., Warren, J. L., McConnell, K., Copple, J. T., Johnson, T., & Gonsalves, G. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002956 · Cited by 31
Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system
Gottesman-Katz, L., Latorre, R., Vanner, S. J., Schmidt, B. L., & Bunnett, N. W. (2020) · Gut · doi:10.1136/gutjnl-2020-321193 · Cited by 31
Beyond Supply: How We Must Tackle the Opioid Epidemic
Srivastava, A. B., & Gold, M. S. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.018 · Cited by 30
Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
Crismale, J. F., & Ahmad, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i47.6799 · Cited by 30
Modeling dynamics of fatal opioid overdose by state and across time
Cooper, R. L., Thompson, J., Edgerton, R. D., Watson, J. A., MacMaster, S. A., Kalliny, M., Huffman, M., Juárez, P. D., Matthews-Juarez, P., Tabatabai, M., et al. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101184 · Cited by 30
Fentanyl epidemic hits the U.S. West Coast: Opioid-related deaths in San Francisco from 2009–2019
West, K. L., Lindquist, K. J., & Rodda, L. N. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103402 · Cited by 30
Bridging institutional logics: Implementing naloxone distribution for people exiting jail in three California counties
Showalter, D., Wenger, L. D., Lambdin, B. H., Wheeler, E., Binswanger, I. A., & Kral, A. H. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114293 · Cited by 30
Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance
Bossert, J. M., Townsend, E. A., Altidor, L., Fredriksson, I., Shekara, A., Husbands, S. M., Sulima, A., Rice, K. C., Banks, M. L., & Shaham, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15679 · Cited by 32
Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study
Marshall, T., Viste, D., Jones, S., Kim, J., Lee, A. J., Jafri, F., Krieg, O., & Ghosh, S. M. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00807-9 · Cited by 33
Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder
Evans, E., Yoo, C. K., Huang, D. Y. C., Saxon, A. J., & Hser, Y. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.08.002 · Cited by 30
Improving patient-provider communication about chronic pain: development and feasibility testing of a shared decision-making tool
Col, N. F., Hull, S., Springmann, V., Ngo, L. H., Merritt, E., GOLD, S. D., Sprintz, M., Genova, N., Nesin, N., Tierman, B., et al. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01279-8 · Cited by 31
Establishment and Implementation of Evidence-Based Opioid Prescribing Guidelines in Cardiac Surgery
Brescia, A. A., Clark, M. J., Theurer, P. F., Lall, S. C., Nemeh, H. W., Downey, R. S., Martin, D. E., Dabir, R. R., Asfaw, Z. E., Robinson, P. L., et al. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.11.015 · Cited by 29
Potassium Channels and Their Potential Roles in Substance Use Disorders
McCoy, M. T., Jayanthi, S., & Cadet, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031249 · Cited by 29
Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities
Xuan, Z., Yan, S., Formica, S. W., Green, T. C., Beletsky, L. A., Rosenbloom, D., Bagley, S. M., Kimmel, S. D., Carroll, J. J., Lambert, A. M., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0109 · Cited by 29
A scoping review of law enforcement drug seizures and overdose mortality in the United States
Cano, M. N., Timmons, P., Hooten, M., Sweeney, K. R., & Oh, S. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104321 · Cited by 29
Polydrug use among heroin users in Cleveland, OH
Bobashev, G., Tebbe, K., Peiper, N. C., & Hoffer, L. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.06.039 · Cited by 29
The hidden costs of the opioid crisis and the implications for financial management in the public sector
Ropero‐Miller, J. D., & Speaker, P. J. (2019) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2019.09.003 · Cited by 29
Temporal trend of drug overdose-related deaths and excess deaths during the COVID-19 pandemic: a population-based study in the United States from 2012 to 2022
Zhao, Y., Liu, Y., Lv, F., He, X., Ng, W. H., Qiu, S., Zhang, L., Xing, Z., Guo, Y., Zu, J., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102752 · Cited by 28
Transition to Nonopioid Analgesia Does Not Impair Pain Control After Major Aesthetic Plastic Surgery
Nguyen, T.-H. C., Lombana, N. F., Zavlin, D., & Moliver, C. L. (2018) · Aesthetic Surgery Journal · doi:10.1093/asj/sjy050 · Cited by 28
From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation
Robinson, A. B., Christensen, A., & Bacon, S. (2018) · Journal of Safety Research · doi:10.1016/j.jsr.2018.10.011 · Cited by 30
Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006–2016
Iwanicki, J. L., Severtson, S. G., Margolin, Z. R., Dasgupta, N., Green, J. L., & Dart, R. C. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304728 · Cited by 28
Effects of Phase Polarity and Charge Balance Spinal Cord Stimulation on Behavior and Gene Expression in a Rat Model of Neuropathic Pain
Vallejo, R., Gupta, A., Kelley, C. A., Vallejo, A., Rink, J. A., Williams, J. M., Cass, C. L., Smith, W. J., Benyamin, R. M., & Cedeño, D. L. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12964 · Cited by 29
The Association Between Mindfulness and Postoperative Pain: A Prospective Cohort Study of Gynecologic Oncology Patients Undergoing Minimally Invasive Hysterectomy
Weston, E., Raker, C., Huang, D., Parker, A. B., Robison, K. M., & Mathews, C. A. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.08.021 · Cited by 28
New‐onset persistent opioid use following breast cancer treatment in older adult women
Roberts, A. W., Fergestrom, N. M., Neuner, J. M., & Winn, A. N. (2019) · Cancer · doi:10.1002/cncr.32593 · Cited by 28
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting
Ataiants, J., Roth, A. M., Mazzella, S., & Lankenau, S. E. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102691 · Cited by 28
A qualitative study of big data and the opioid epidemic: recommendations for data governance
Evans, E., Delorme, E., Cyr, K. D., & Goldstein, D. M. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00544-9 · Cited by 28
Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California’s prescription drug monitoring program
Castillo‐Carniglia, Á., Cruz, A. G., Cerdá, M., Delcher, C., Shev, A. B., Wintemute, G. J., & Henry, S. G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108405 · Cited by 28
Efficacy and Safety of Intranasal Ketamine for Acute Pain Management in the Emergency Setting: A Systematic Review and Meta-Analysis
Seak, Y. S., Nor, J., Kamauzaman, T. H. T., Abdullah, A. A., & Islam, M. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173978 · Cited by 28
Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome
van Hoogdalem, M. W., Johnson, T. N., McPhail, B. T., Kamatkar, S., Wexelblatt, S. L., Ward, L. P., Christians, U., Akinbi, H. T., Vinks, A. A. T. M. M., & Mizuno, T. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2458 · Cited by 28
An ecological study of temporal trends in ‘deaths of despair’ in England and Wales
Augarde, E., Gunnell, D., Mars, B., & Hickman, M. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02251-9 · Cited by 29
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
Meyerson, B. E., Bentele, K. G., Russell, D. M., Brady, B. R., Downer, M., Garcia, R. C., Garnett, I., Lutz, R., Mahoney, A. N., Samorano, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274094 · Cited by 28
Necrotic Upper-Extremity Infections in People Who Inject Drugs: A Case Series
Soderquist, M. C., Delgado, G., Abdelfattah, H. M., Thoder, J. J., & Solarz, M. K. (2023) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2023.04.001 · Cited by 28
Lipid emulsion in local anesthetic toxicity
Harvey, M. G., & Cave, G. (2017) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000498 · Cited by 28
A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016
Smith, N., Martins, S. S., Kim, J. M., Rivera‐Aguirre, A., Fink, D. S., Castillo‐Carniglia, Á., Henry, S. G., Mooney, S. J., Marshall, B. D. L., Davis, C. S., et al. (2018) · Addiction · doi:10.1111/add.14440 · Cited by 28
Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting
Godersky, M. E., Klein, J. W., Merrill, J. O., Blalock, K. L., Saxon, A. J., Samet, J. H., & Tsui, J. I. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000608 · Cited by 28
Development of a take-home naloxone program at an urban academic emergency department
Eswaran, V., Allen, K. C., Cruz, D. S., Lank, P. M., McCarthy, D. M., & Kim, H. S. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.06.017 · Cited by 28
Impact of reported NSAID “allergies” on opioid use disorder in back pain
Li, L., Chang, Y., Song, S., Losina, E., Costenbader, K. H., & Laidlaw, T. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.025 · Cited by 29
Anxiety sensitivity and pain intensity independently predict opioid misuse and dependence in chronic pain patients
Smit, T., Rogers, A. H., Garey, L., Allan, N. P., Viana, A. G., & Zvolensky, M. J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113523 · Cited by 28
The Opioid Epidemic Was Not Caused by Economic Distress But by Factors that Could be More Rapidly Addressed
Currie, J., & Schwandt, H. (2020) · National Bureau of Economic Research · doi:10.3386/w27544 · Cited by 28
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis
Santo, T., Gisev, N., Campbell, G., Colledge‐Frisby, S., Wilson, J., Tran, L. T., Lynch, M. A., Martino-Burke, D., Taylor, S., & Degenhardt, L. J. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104434 · Cited by 27
Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis
Lim, T. Y., Dong, H., Stringfellow, E. J., Hasgül, Z., Park, J. N., Glos, L. J., Kazemi, R., & Jalali, M. S. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100898 · Cited by 27
Characterizing trends in methamphetamine-related health care use when there is no ICD code for “methamphetamine use disorder”
Shearer, R. D., Shippee, N. D., & Winkelman, T. N. A. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108369 · Cited by 27
Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation
Collins, A. B., Beaudoin, F. L., Samuels, E. A., Wightman, R., & Baird, J. B. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108411 · Cited by 27
“Know your epidemic, know your response”: Epidemiological assessment of the substance use disorder crisis in the United States
Hernández, A., Lan, M., MacKinnon, N. J., Branscum, A. J., & Cuadros, D. F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251502 · Cited by 27
Housing Instability, Structural Vulnerability, and Non-Fatal Opioid Overdoses Among People Who Use Heroin in Washington Heights, New York City
Pérez‐Figueroa, R., Obonyo, D. J., Santoscoy, S., Surratt, H. L., Lekas, H., Lewis, C. F., Lyons, J. S., & Amesty, S. C. (2021) · Behavioral Medicine · doi:10.1080/08964289.2021.1922347 · Cited by 27
A Quality Improvement Initiative Featuring Peer-Comparison Prescribing Feedback Reduces Emergency Department Opioid Prescribing
Andereck, J. W., Reuter, Q. R., Allen, K. C., Ansari, S., Quarles, A. R., Cruz, D. S., VanZalen, L., Malik, S., McCarthy, D. M., & Kim, H. S. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2019.07.008 · Cited by 27
ICD-10-CM–Based Definitions for Emergency Department Opioid Poisoning Surveillance: Electronic Health Record Case Confirmation Study
Slavova, S. S., Quesinberry, D. B., Costich, J. F., Pasalic, E., Martinez, P., Martin, J., Eustice, S., Akpunonu, P., & Bunn, T. L. (2020) · Public Health Reports · doi:10.1177/0033354920904087 · Cited by 28
Electrochemical N -Demethylation of 14-Hydroxy Morphinans: Sustainable Access to Opioid Antagonists
Glotz, G., Kappe, C. O., & Cantillo, D. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c02424 · Cited by 27
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island
Zang, X., Bessey, S. E., Krieger, M. S., Hallowell, B. D., Koziol, J. A., Nolen, S., Behrends, C. N., Murphy, S. M., Walley, A. Y., Linas, B. P., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.41174 · Cited by 26
Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions
Chatterjee, A., Baker, T. J., Rudorf, M., Walt, G., Stotz, C., Martin, A., Kinnard, E. N., McAlearney, A. S., Bosak, J., Medley, B., et al. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209272 · Cited by 26
Expression of immediate early genes in brain reward circuitries: Differential regulation by psychostimulant and opioid drugs
Bisagno, V., & Cadet, J. L. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.004 · Cited by 26
Stewarding Recovery from the Opioid Crisis Through Health System Initiatives
Perrone, J., Weiner, S. G., & Nelson, L. S. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2018.11.39013 · Cited by 27
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019
Shrestha, S., Stopka, T. J., Hughto, J. M. W., Case, P., Palacios, W. R., Reilly, B., & Green, T. C. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00538-9 · Cited by 26
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Abadi, Y. R., Gholami, J., Noroozi, A., Ansari, M., Baheshmat, S., Hamzehzadeh, M., Ghadirzadeh, M. R., Vahdani, B., Ekhtiari, H., Mojtabai, R., et al. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103529 · Cited by 26
Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder
Namchuk, A. B., Lucki, I., & Browne, C. A. (2022) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2022.10254 · Cited by 29
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
Yunusa, I. U., Gagne, J. J., Yoshida, K., & Bykov, K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0194 · Cited by 26
Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
Mintz, C. M., Xu, K. Y., Presnall, N. J., Hartz, S. M., LEVIN, F. R., Scherrer, J. F., Bierut, L. J., & Grucza, R. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.11634 · Cited by 26
Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics
Jawa, R., Tin, Y., Nall, S. K., Calcaterra, S. L., Savinkina, A. A., Marks, L. R., Kimmel, S. D., Linas, B. P., & Barocas, J. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.7888 · Cited by 27
How Clinicians Caring for Youth Can Address the Opioid-Related Overdose Crisis
Hadland, S. E. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2019.05.008 · Cited by 26
Who Receives Naloxone from Emergency Medical Services? Characteristics of Calls and Recent Trends
Geiger, C. K., Smart, R., & Stein, B. D. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1640832 · Cited by 27
Opioid Prescribing Patterns and Overdose Deaths in Texas
Champagne‐Langabeer, T., Madu, R., Giri, S., Stotts, A. L., & Langabeer, J. R. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1675114 · Cited by 27
Histone modifications in cocaine, methamphetamine and opioids
Cheng, J., He, Z., Chen, Q., Jiang, L., Peng, Y., Zhang, J., Yan, X., Yan, J., & Niu, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16407 · Cited by 26
Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021
Rock, P. J., Slavova, S. S., Westgate, P. M., Nakamura, A., & WALSH, S. L. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111062 · Cited by 26
Randomized comparison of two web-based interventions on immediate and 30-day opioid overdose knowledge in three unique risk groups
Bergeria, C. L., Huhn, A. S., & Dunn, K. E. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.05.006 · Cited by 25
Factors associated with incomplete toxicology reporting in drug overdose deaths, 2010–2016
Tote, K. M., Bradley, H. M., Martin, E. G., Yucel, R. M., & Rosenberg, E. S. (2019) · Annals of Epidemiology · doi:10.1016/j.annepidem.2019.08.006 · Cited by 25
Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction
Damiescu, R., Banerjee, M., Lee, D. Y. W., Paul, N. W., & Efferth, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010341 · Cited by 28
Trends in Drug Overdose Mortality Rates in Kentucky, 2019-2020
Slavova, S. S., Quesinberry, D. B., Hargrove, S. L., Rock, P. J., Brancato, C. J., Freeman, P. R., & WALSH, S. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16391 · Cited by 25
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial
Marshall, B. D. L., Alexander-Scott, N. E., Yedinak, J. L., Hallowell, B. D., Goedel, W. C., Allen, B., Schell, R. C., Li, Y., Krieger, M. S., Pratty, C., et al. (2021) · Addiction · doi:10.1111/add.15731 · Cited by 25
The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study
Karnik, N. S., Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D. A., Ghitza, U. E., Hefner, K. R., et al. (2022) · Addiction · doi:10.1111/add.15875 · Cited by 26
Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
Adeosun, S. O. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221097173 · Cited by 25
Systematic Review of Naloxone Dosing and Adverse Events in the Emergency Department
Yugar, B., McManus, K., Ramdin, C., Nelson, L. S., & Parris, M. A. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2023.05.006 · Cited by 25
Fentanyl and other New Psychoactive Synthetic Opioids. Challenges to Prevention and Treatment
Albores‐García, D., & Cruz, S. L. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000109 · Cited by 25
Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival
Calle, P. A., Maudens, K. E. K., Lemoyne, S., Geerts, S., Sassenbroeck, D. V., Jensen, P., Overloop, J. V., Deconinck, E., & Blanckaert, P. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.03.047 · Cited by 25
Opioid Prescriptions After Hemorrhoidectomy
Lu, P. W., Fields, A. C., Andriotti, T., Welten, V. M., Rojas-Alexandre, M., Koehlmoos, T. P., Schoenfeld, A. J., & Melnitchouk, N. (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001570 · Cited by 25
Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries
Peters, J. L., Durand, W. M., Monteiro, K. A., Dumenco, L. L., & George, P. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.06.180152 · Cited by 25
Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts
Lim, J. K., Forman, L. S., Ruiz, S., Xuan, Z., Callis, B. P., Cranston, K., & Walley, A. Y. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.033 · Cited by 24
Regulatory Policies for Alcohol, other Psychoactive Substances and Addictive Behaviours: The Role of Level of Use and Potency. A Systematic Review
Rehm, J. T., Crépault, J., Hasan, O. S. M., Lachenmeier, D. W., Room, R., & Sornpaisarn, B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193749 · Cited by 24
Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology
Hill, R., & Canals, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107961 · Cited by 25

Authors: Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M.
ORCID: Hedegaard, Holly
Publisher: National Center for Health Statistics ( U.S.)
Published: 2021-12-30
DOI: 10.15620/cdc:112340
OpenAlex: W4200337926
Cited by: 1,283
References: 4
Citations by year: 2026: 25 · 2025: 93 · 2024: 130 · 2023: 186 · 2022: 147 · 2021: 168
Type: report
Language: en
Open access: gold
doi.org
Licence: public-domain
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Keywords: drug overdose deaths, opioid overdose, stimulant overdose, mortality trends, drug-related deaths, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug Overdose Deaths in the United States, 1999–2020

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks